Internal Medicine, Infectious Disease · Las Vegas, NV
NPI
1275511263
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
3483 S Eastern Ave
Las Vegas, NV, 89169
Phone (702) 309-2311
Groups this clinician bills Medicare through
Medicare paid, 2024
$491K
193,192 services
Medicare patients, 2024
723
Average age 73
Drug cost, 2024
$1.8M
1,085 prescriptions
Company payments, 2025
$1,049
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald A Shockley was code 99232 (hospital e&m - subsequent), 3,981 times for 462 patients. In total Ronald A Shockley billed 193,192 services in 41 codes, and Medicare paid $491K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,981 | 462 | $60.28 | $240K |
| 99223 Hospital E&M - Initial | Facility | 361 | 285 | $132.65 | $48K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 290 | 74 | $80.31 | $23K |
| 99091 E&M - Miscellaneous | Office | 246 | 69 | $41.22 | $10K |
| 99213 Office E&M - Established | Office | 231 | 109 | $60.93 | $14K |
| 96365 Intravenous Infusion, Hydration | Office | 217 | 34 | $48.37 | $10K |
| 96374 Injection Administration | Office | 216 | 12 | $28.40 | $6,135 |
| 99233 Hospital E&M - Subsequent | Facility | 203 | 164 | $90.88 | $18K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 192 | 21 | $0.52 | $99.32 |
| 36415 Venipuncture Blood Collection | Office | 99 | 58 | $8.65 | $856 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 76 | 45 | $32.63 | $2,480 |
| 99211 Office E&M - Established | Office | 68 | 41 | $17.92 | $1,219 |
| 99203 Office E&M - New | Office | 64 | 64 | $84.50 | $5,408 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 63 | 52 | $41.58 | $2,620 |
| 99214 Office E&M - Established | Office | 18 | 15 | $94.13 | $1,694 |
By year: 2022 $826K for 171,815 services; 2023 $628K for 228,024 services; 2024 $491K for 193,192 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 99 | 58 | $8.65 | $856 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald A Shockley prescribed most often to Medicare patients was Daptomycin, with 151 prescriptions and refills. In total Ronald A Shockley wrote 1,085 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 151 | 151 | 28 | $264K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 128 | 128 | 16 | $539K |
| Ertapenem Ertapenem Sodium | 82 | 82 | 20 | $51K |
| Cefepime Hcl Generic | 76 | 76 | 17 | $16K |
| Fosfomycin Tromethamine Generic | 55 | 69 | 21 | $15K |
| Ceftriaxone Ceftriaxone Sodium | 37 | 37 | Under 11 | $4,778 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 37 | 37 | Under 11 | $146K |
| Meropenem Generic | 36 | 36 | Under 11 | $7,690 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 30 | 30 | Under 11 | $3,545 |
| Doxycycline Hyclate Generic | 29 | 46 | 14 | $691 |
| Cephalexin Generic | 27 | 33 | 11 | $213 |
| Juluca Dolutegravir/Rilpivirine | 25 | 25 | Under 11 | $86K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 21 | 21 | Under 11 | $358 |
| Micafungin Micafungin Sodium | 20 | 20 | Under 11 | $6,183 |
| Cabenuva Cabotegravir/Rilpivirine | 19 | 33 | Under 11 | $123K |
Brand drugs: - claims; generic drugs: 699 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald A Shockley $1,049 ($1,049 in general payments such as food, travel and fees) from 8 companies. The largest payer was ViiV Healthcare Company with $302.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.